Pusan National University Researchers Dive Deep Into the Safety of JAK Inhibitors for Atopic Dermatitis

BUSAN, South Korea, Dec. 15, 2023 /PRNewswire/ — Atopic dermatitis (or AD) is a heterogenous, inflammatory condition of the skin and is usually accompanied by itch, redness, and swelling. AD can have a significant impact on the patient’s quality of life. While several biologic treatment…